Bonnie L. Bassler, Director of Royalty Pharma RPRX, has filed 0 purchases and 14 sales on the open market. Over the past 12 months that comes to a net sale of $1.8M. The latest trade was on 09/30.

BB

BB

Bonnie L. Bassler

Director

Company

Royalty Pharma RPRX

First filing

23/01/03

Trades

82 trades

Buys / sales

0 / 14

12-month net buying

−$1.8M

Last trade

09/30

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Regeneron PharmaceuticalsREGN	Open-market sale10b5-1 plan	01/07	01/08	1,500 sh	$800.00	$1,200,000	−46.8%
Regeneron PharmaceuticalsREGN	Open-market sale10b5-1 plan	25/11/20	25/11/24	760 sh	$750.00	$570,000	−32.9%
Regeneron PharmaceuticalsREGN	Open-market sale10b5-1 plan	24/08/15	24/08/19	756 sh	$1,170.00	$884,520	−35.4%
Regeneron PharmaceuticalsREGN	Open-market sale10b5-1 plan	24/08/02	24/08/05	756 sh	$1,115.00	$842,940	−35.4%
Regeneron PharmaceuticalsREGN	Open-market sale10b5-1 plan	24/06/24	24/06/25	756 sh	$1,062.00	$802,872	−35.4%
Regeneron PharmaceuticalsREGN	Open-market sale10b5-1 plan	24/06/05	24/06/07	827 sh	$1,011.00	$836,097	−37.4%
Regeneron PharmaceuticalsREGN	Open-market sale	24/02/26	24/02/26	854 sh	$979.25	$836,279.5	−38.2%
Regeneron PharmaceuticalsREGN	Open-market sale10b5-1 plan	24/01/30	24/01/31	827 sh	$959.00	$793,093	−37.4%
Regeneron PharmaceuticalsREGN	Open-market sale10b5-1 plan	24/01/03	24/01/04	826 sh	$914.00	$754,964	−37.4%
Regeneron PharmaceuticalsREGN	Open-market sale10b5-1 plan	23/12/13	23/12/14	610 sh	$870.00	$530,700	−32.8%
Regeneron PharmaceuticalsREGN	Open-market sale10b5-1 plan	23/08/21	23/08/23	853 sh	$829.00	$707,137	−40.6%
Regeneron PharmaceuticalsREGN	Open-market sale10b5-1 plan	23/08/10	23/08/11	853 sh	$789.00	$673,017	−40.6%
Regeneron PharmaceuticalsREGN	Open-market sale10b5-1 plan	23/03/24	23/03/27	1,240 sh	$818.00	$1,014,320	−49.9%
Regeneron PharmaceuticalsREGN	Open-market sale	23/02/03	23/02/07	1,021 sh	$779.00	$795,359	−45.0%